Skip to main content
. Author manuscript; available in PMC: 2008 Oct 1.
Published in final edited form as: Surgery. 2007 Oct;142(4):487–496.e2. doi: 10.1016/j.surg.2007.08.007

Table.

Baseline parameters

Experimental group A1 (μm) A2 (μm) pA3 (μm) dA3 (μm) A1 flow(nL/s) FCD
capillary/field
Hemorrhagic shock + conventional resuscitation 86 ± 3 40 ± 5 14 ± 1 11 ± 1 147 ± 6 5.5 ± 0.54
Hemorrhagic shock + conventional resuscitation + amiloride simultaneously with resuscitation 89 ± 5 28 ± 4 14 ± 1 10 ± 1 145 ± 6 5.3 ± 0.19
Hemorrhagic shock + conventional resuscitation + amiloride preemptively at the beginning of hemorrhagic shock 87 ± 3 38 ± 3 13 ± 1 9 ± 0.3 130 ± 11 5.2 ± 0.40
Hemorrhagic shock + conventional resuscitation + DPR 92 ± 3 37 ± 5 12 ± 1 10 ± 0.4 160 ± 11 5.2 ± 0.34
Hemorrhagic shock + conventional resuscitation + DPR + amiloride simultaneously with resuscitation 90 ± 3 35 ± 5 14 ± 1 10 ± 0.3 144 ± 12 4.5 ± 0.24
Sham control + amiloride 87 ± 3 30 ± 4 13 ± 1 11 ± 1 161 ± 13 4.7 ± 0.24